Soluble NKG2D ligands: prevalence, release, and functional impact
Helmut Rainer Salih, Stefan Holdenrieder, Alexander Steinle
[Frontiers in Bioscience 13, 3448-3456, May 1, 2008]

Involvement of cystatin C in pathophysiology of CNS diseases
Atsushi Nagai, Masaharu Terashima, Abdullah Md Sheikh, Yoshitomo Notsu, Koichi Shimode, Shuhei Yamaguchi, Shotai Kobayashi, Seung U. Kim, Junichi Masuda
[Frontiers in Bioscience 13, 3470-3479, May 1, 2008]

Cystatin protease inhibitors and immune functions
Tina Zavasnik-Bergant
[Frontiers in Bioscience 4625-4637, May 1, 2008]

Cystatin protease inhibitors and immune functions
Tina Zavasnik-Bergant
[Frontiers in Bioscience 4625-4637, May 1, 2008]

Cystatins: Biochemical and structural properties, and medical relevance
Vito Turk, Veronika Stoka, Dusan Turk
[Frontiers in Bioscience 5406-5420, May 1, 2008]

Cystatin C and cathepsins in cardiovascular disease
Eva Bengtsson, Jan Nilsson, Stefan Jovinge
[Frontiers in Bioscience 13, 5780-5786, May 1, 2008]

Epigenetic regulation of cystatins in cancer
Ashley G. Rivenbark, William B. Coleman
[Frontiers in Bioscience 14, 453-462, January 1, 2009]

Cystatins and cancer
James L. Cox
[Frontiers in Bioscience 14, 463-474, January 1, 2009]